Pharmacovigiliance Study on Karuppu Vishnu Chakkara Mathirai

Pharmacovigiliance study on Karuppu Vishnu Chakkara Mathirai,herbo mineral formulation prescribed in NIS

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Observational

Source

CTRI

Registry ID

CTRI/2020/07/026732

Enrollment

200

Registered

2020-07-22

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: OPD and IPD Patients in Ayothidoss Pandithar Hospital

Exclusion criteria

Exclusion criteria: patient who were under the allopathic or any other alternative medication. Patients with history of any serious illness Any H/o drug allergy

Design outcomes

Primary

Measure	Time frame
Provide information about the adverse drug effects of patients treated with karuppu vishnu chakra mathirai. Timepoint: 6 months	—

Secondary

Measure	Time frame
Provide information about the adverse drug effectsTimepoint: 6 months	—

Countries

India

Contacts

Public ContactDrDVelaman

National Institute of Siddha

mariappannis@gmail.com9894690733

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026